Drug Shortage Report for SANDOZ TELMISARTAN

Last updated on 2019-06-12 History
Report ID 76233
Drug Identification Number 02375958
Brand name SANDOZ TELMISARTAN
Common or Proper name TELMISARTAN
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) TELMISARTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-11-05
Estimated end date 2019-09-30
Actual end date
Shortage status Actual shortage
Updated date 2019-06-12
Company comments Sandoz not able to meet 100 pour-cent of the market demand following competition shortage situation. Limited supply availability distributed based on historical sales.
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-06-12 French Compare
v7 2019-06-12 English Compare
v6 2019-05-07 French Compare
v5 2019-05-07 English Compare
v4 2019-04-10 French Compare
v3 2019-04-10 English Compare
v2 2019-02-18 French Compare
v1 2019-02-18 English Compare